Executive summary: Japanese guidelines for atopic dermatitis (ADGL) 2021

…, H Arakawa, S Ichiyama, T Katsunuma… - Allergology …, 2022 - jstage.jst.go.jp
… epidermal keratinocytes, activate group 2 innate lymphoid cells (ILC2) and T helper 2 (Th2)
cells at the lesion site, inducing type 2 immune responses. Such immune responses lead to …

[HTML][HTML] Reproducibility of food challenge to cow's milk: Systematic review with individual participant data meta-analysis

…, HA Sampson, M Maeda, T Katsunuma… - Journal of Allergy and …, 2022 - Elsevier
Background Cow’s milk (CM) is an increasingly common cause of severe allergic reactions,
but there is uncertainty with respect to severity of reactions at low-level CM exposure, as well …

Periostin as a biomarker for the diagnosis of pediatric asthma

…, S Ohta, J Ono, K Izuhara, T Katsunuma - Pediatric Allergy and …, 2016 - Wiley Online Library
Background There are some biomarkers for asthma diagnosis but they are often difficult in
clinical use, particularly in pediatric cases. Periostin is an extracellular matrix protein, …

Evaluation of the staphylococcal exotoxins and their specific IgE in childhood atopic dermatitis

…, T Katsunuma, Y Ohya, N Ikeda, T Takeda… - Journal of allergy and …, 1999 - Elsevier
… Superantigens activate T cells in a nonspecific manner against antigens. Several studies …
antigens of T cells from healthy donors. Intracutaneous injection of SEB induces a T cell–…

English version of clinical practice guidelines for the management of atopic dermatitis 2021

…, H Arakawa, S Ichiyama, T Katsunuma… - The Journal of …, 2022 - Wiley Online Library
… This is an X-linked recessive inherited disease caused by an abnormality of the WASP gene
and is characterized by immunodeficiency (T-cell dysfunction), thrombopenia, and refractory …

Long-term safety, efficacy, pharmacokinetics and pharmacodynamics of omalizumab in children with severe uncontrolled asthma

…, T Katsunuma, K Kurihara, T Teramoto… - Allergology …, 2017 - jstage.jst.go.jp
… However, the effects of long-term treatment with omalizumab in this population haven't
been well investigated. The objective of this study is to evaluate the long-term safety, efficacy, …

Gene expression screening of human mast cells and eosinophils using high-density oligonucleotide probe arrays: abundant expression of major basic protein in mast …

…, H Tomita, K Yuki, T Katsunuma… - Blood, The Journal …, 2001 - ashpublications.org
Mast cells (MCs) and eosinophils are thought to play important roles in evoking allergic
inflammation. Cell-type–specific gene expression was screened among 12 000 genes in human …

The Japanese respiratory society guidelines for the management of cough and sputum (digest edition)

…, T Kaneko, Y Obase, M Shinkai, T Katsunuma… - Respiratory …, 2021 - Elsevier
Cough and sputum are common complaints at outpatient visits. In this digest version, we
provide a general overview of these two symptoms and discuss the management of acute (up to …

Effect of oral immunotherapy in children with milk allergy: the ORIMA study

…, H Morita, K Matsumoto, T Katsunuma - Allergology …, 2021 - jstage.jst.go.jp
Background: This study was aimed at evaluating the efficacy and safety of oral immunotherapy
(OIT) in children with severe cow's milk allergy. Methods: The subjects comprised 28 …

Omalizumab in Japanese children with severe allergic asthma uncontrolled with standard therapy

…, K Ito, S Doi, K Yamaguchi, T Katsunuma… - Allergology …, 2015 - jstage.jst.go.jp
Background: Omalizumab has demonstrated clinical benefits in children with moderate to
severe allergic asthma. However, no studies have been performed in Japanese asthmatic …